Loading…
CIK 0001395064 • 3 13F filings • May 12, 2025 – Nov 13, 2025
Import this data to Google Sheets with:
=jivedata("takeda-pharmaceutical-co-ltd","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 3 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| American Well Corporation | COM | $478K | 2.9%Prev: 3.5% | 77,733 SH | Decreased |
| Equillium, Inc. | COM | $2.6M | 15.9%Prev: 2.9% | 1,824,977 SH | Increased |
| Lyell Immunopharma, Inc. | COM | $891K | 5.4%Prev: 1.9% | 54,887 SH | Increased+13,722 SH |
| Ovid Therapeutics, Inc. | COM | $9.8M | 59.8%Prev: 12.7% | 7,531,996 SH | Increased |
| Rani Therapeutics Holdings, Inc. | COM | $102K | 0.6%Prev: 0.5% | 203,190 SH | Decreased |
| Shattuck Labs, Inc. | COM | $1.2M | 7.5%Prev: 2.1% | 515,619 SH | Increased |
| Standard Biotools, Inc. | COM | $21K | 0.1%Prev: 0.1% | 16,515 SH | Increased |
| Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | COM | $1.2M | 7.6%Prev: 5.1% | 1,475,121 SH | Increased |
| 13F-HR |
| 0001395064-25-000055 |
| $16.2M |
| View |